DRUGS see also Crime; Pharmaceuticals

Amendments

FDA: making continuing appropriations (H.J. Res. 77), consideration (H. Res. 371), H6251, H6253 [4OC]

——— strengthen regulation of compounding drugs by pharmacies (S. 959), S6080, S6081 [30JY]

——— strengthen regulation of human drug compounding and drug supply chain security (H.R. 3204), S7683, S7684 [30OC], S8008 [13NO], S8026, S8057 [14NO]

Articles and editorials

Mexico Children Used as ‘‘Mules’’ by Drug Gangs, H5047 [24JY]

Bills and resolutions

Alaska: enter into intergovernmental agreements with Indian tribes relative to enforcement of certain State laws by Indian tribes, improve quality of life in rural Alaska, and reduce alcohol and drug abuse (see S. 1474), S6208 [1AU]

Animals: condemn practice of gassing stray cats and dogs (see H. Res. 433), H7567 [5DE]

——— disapprove use of gas chambers to euthanize shelter animals and support State laws requiring the use of drugs for euthanasia by animal shelters (see H. Res. 208), H2533 [8MY]

Cocaine: apply reduced sentences for certain cocaine based offenses retroactively for certain offenders (see H.R. 2369), H3591 [13JN]

Commission on Native Children: establish (see S. 1622), S7674 [30OC]

Contraceptives: establish certain duties for pharmacies to ensure provision of FDA-approved contraception (see S. 333), S772 [14FE] (see H.R. 728), H546 [14FE]

Controlled Substances Act: exclude industrial hemp from the definition of marijuana (see S. 359), S773 [14FE] (see H.R. 525), H410 [6FE]

——— make any substance containing hydrocodone a schedule II drug (see S. 621), S2026 [20MR] (see H.R. 1285), H1718 [20MR]

——— place synthetic drugs in Schedule I indicating high potential for abuse, no current accepted medical use, and lack of accepted safety for use under medical supervision (see H.R. 315), H176 [18JA]

Correctional institutions: provide for an effective HIV/AIDS program in Federal prisons (see H.R. 895), H814 [28FE]

Courts: clarify circumstances under which the enhanced penalty provisions for subsequent convictions apply (see H.R. 2405), H3687 [17JN]

Crime: address sentencing disparity between crack and powder cocaine (see H.R. 2372), H3591 [13JN]

——— concentrate Federal resources aimed at the prosecution of drug offenses on major offenses (see H.R. 3088), H5546 [12SE]

——— deploy Border Patrol agents and increase number of DEA and ATF agents along U.S. border to identify and eliminate illicit sources of firearms smuggled into Mexico for use by drug traffickers (see H.R. 72), H30 [3JA]

——— enhance penalties for marketing controlled substances to minors (see S. 1686), S7951 [12NO]

Cuba: facilitate export of U.S. agricultural products, remove impediments to export of medical devices and medicines, allow travel by U.S. citizens, and establish an agricultural export promotion program (see H.R. 873), H701 [27FE]

DEA: anniversary (see S. Res. 178), S4793 [20JN] (see H. Res. 272), H3989 [20JN]

Dept. of Education: repeal suspension of eligibility for grants, loans, and work assistance for drug-related offenses (see H.R. 3510), H7152 [15NO]

Dept. of HHS: amend and reauthorize the Controlled Substance Monitoring Program (see H.R. 3528), H7187 [18NO]

——— award certain asthma-related grants to States that permit trained school personnel to administer epinephrine (see S. 1503), S6446 [12SE] (see H.R. 2094), H2910 [22MY]

——— conduct or support a comprehensive study comparing total health outcomes, including risk of autism, in vaccinated populations and unvaccinated populations (see H.R. 1757), H2351 [25AP]

——— establish a drug-free workplace information clearinghouse, support methamphetamine treatment programs for pregnant and parenting women, and improve prevention and treatment of addiction (see H.R. 752), H594 [15FE]

——— grant provisional approval to fast-tracked drugs used in therapies and treatments for life-threatening diseases (see H.R. 2090), H2910 [22MY]

——— limit copayment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the amount applicable to drugs in a non-preferred brand drug tier (see H.R. 460), H341 [4FE]

——— prevent abuse of dextromethorphan by restricting over-the-counter sales and bulk distribution (see S. 644), S2146 [21MR]

——— promulgate regulations on patient medication information to ensure patients receive consistent and high-quality information about prescription drugs (see S. 752), S2749 [17AP] (see H.R. 1608), H2124 [17AP]

——— provide for public disclosure of charges for certain hospital and ambulatory surgical center treatment episodes (see H.R. 2853), H5173 [30JY]

——— provide grants for treatment of heroin, cocaine, methamphetamine, ecstasy, and PCP abuse (see H.R. 2130), H2952 [23MY]

Dept. of Homeland Security: develop a comprehensive strategy to gain and maintain operational control of the international borders of the U.S. (see S. 683), S2501 [9AP] (see H.R. 1417), H1856 [9AP]

Dept. of Justice: authorize veterans’ treatment courts and encourage services for veterans through drug courts (see H.R. 2187), H2954 [23MY]

——— provide the Depts. of Defense and Veterans Affairs authority to establish a prescription drug take-back program for Armed Forces members and veterans (see S. 1089), S3954 [4JN] (see H.R. 3714), H8107 [12DE]

——— provide with additional tools to target extraterritorial drug trafficking activity (see S. 706), S2589 [11AP] (see H.R. 2114), H2911 [22MY]

Dept. of Transportation: recognize hair as an alternative specimen for preemployment and random controlled substances testing of commercial motor vehicle drivers (see S. 1625), S7674 [30OC] (see H.R. 3403), H6952 [30OC]

Dept. of Veterans Affairs: implement mental health care and rehabilitation program for veterans with service-related post-traumatic stress disorder, depression, anxiety disorder, or related substance use disorder (see S. 819), S3028 [25AP]

——— provide for certain requirements relative to immunization of veterans (see S. 1165), S4481 [13JN]

Diseases: commend progress made by anti-tuberculosis programs (see H. Res. 133), H1825 [21MR]

——— de-link research and development incentives from drug prices for new medicines to treat HIV/AIDS and stimulate greater sharing of scientific knowledge (see S. 626), S2026 [20MR]

——— reduce disparities and improve access to diagnosis and treatment of prostate cancer for underserved populations and men with a family history of prostate cancer (see S. 516), S1592 [11MR]

——— require group and individual health insurance coverage and group health plans to cover oral cancer drugs on terms no less favorable than for cancer medications administered by a health care provider (see S. 1879), S9052 [19DE] (see H.R. 1801), H2392 [26AP]

Drug abuse: establish a commission to coordinate efforts to reduce prescription drug abuse (see S. 1277), S5620 [10JY]

Drug testing: prohibit the manufacture, marketing, sale, or shipment of products designed to assist in defrauding a drug test (see H.R. 1930), H2568 [9MY]

EPA: allow for the distribution, sale, and consumption of remaining inventories of over-the-counter chlorofluorocarbon (CFC) epinephrine inhalers (see H.R. 1220), H1547 [15MR]

FDA: approve certain drugs and biological products for use in a limited population of patients to address increases in bacterial and fungal resistance to drugs and biological products (see H.R. 3742), H8108 [12DE]

——— encourage use of abuse-deterrent formulations of drugs (see S. Res. 97), S2649 [15AP] (see H. Res. 161), H2026 [15AP]

——— enhance reporting requirements pertaining to use of antimicrobial drugs in food animals (see H.R. 820), H658 [26FE]

——— ensure valid generic drugs may enter the market (see S. 504), S1269 [7MR]

——— exempt certain user fees from budget sequestration (see S. 1413), S6126 [31JY] (see H.R. 2725), H4724 [18JY]

——— improve ability to study use of antimicrobial drugs in food-producing animals (see S. 895), S3256 [8MY]

——— making continuing appropriations (see H.J. Res. 77), H6223 [3OC]

——— making continuing appropriations (H.J. Res. 77), consideration (see H. Res. 371), H6223 [3OC]

——— modify approval of any drug containing controlled-release oxycodone hydrochloride to limit such approval to use for relief of severe-only pain (see H.R. 1366), H1823 [21MR]

——— permit the sale of, and access to, ‘‘research use only’’ products in diagnostic tests (see H.R. 3005), H5397 [2AU]

——— prohibit wholesalers from purchasing prescription drugs from pharmacies and enhance information and transparency of drug wholesalers engaged in interstate commerce (see H.R. 1958), H2602 [14MY]

——— provide incentives for the development of new combination drugs (see H.R. 2985), H5396 [2AU]

——— reauthorize user fee programs relating to generic new animal drugs (see H.R. 1408), H1856 [9AP]

——— reauthorize user fee programs relating to new animal drugs (see H.R. 1407), H1856 [9AP]

——— reauthorize user fee programs relating to new animal drugs and generic new animal drugs (see S. 622), S2026 [20MR]

——— require the label of drugs to contain a parenthetical statement identifying the source of any ingredient constituting or derived from a grain or starch-containing ingredient (see H.R. 2003), H2654 [15MY]

——— strengthen and secure the pharmaceutical distribution supply chain to protect consumers from counterfeit pharmaceuticals (see S. 957), S3531 [15MY] (see H.R. 1919), H2567 [9MY]

——— strengthen regulation of compounding drugs by pharmacies (see S. 959), S3531 [15MY] (see H.R. 2186), H2954 [23MY] (see H.R. 3019), H5397 [2AU] (see H.R. 3089), H5546 [12SE]

——— strengthen regulation of human drug compounding and drug supply chain security (see H.R. 3204), H5921 [27SE]

——— waive or reduce certain fees applicable to generic drug facilities if such fees present a significant barrier to market entry due to limited resources or other circumstances (see H.R. 3631), H7394 [2DE]

Federal employees: ensure Federal Employees Health Benefit Program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits (see H.R. 1367), H1823 [21MR]

FEMA: codify authority to use Urban Areas Security Initiative and State Homeland Security Grant Program funding for enhancing medical preparedness, medical surge capacity, and mass prophylaxis capabilities (see H.R. 1791), H2391 [26AP]

Financial institutions: create protections for depository institutions that provide financial services to marijuana-related businesses (see H.R. 2652), H4369 [10JY]

Firearms: enhance criminal penalties for straw purchasers of firearms (see H.R. 404), H280 [23JA]

——— provide exceptions from firearm prohibitions otherwise applicable relative to marijuana if its possession is lawful under State law (see H.R. 3483), H7109 [14NO]

Government regulations: increase Federal oversight of prescription opioid treatment and assistance to States in reducing opioid abuse, diversion, and deaths (see S. 348), S772 [14FE] (see H.R. 672), H501 [13FE]

Health: enhance efforts to address antimicrobial resistance (see H.R. 2285), H3250 [6JN]

——— extend health information technology assistance eligibility to behavioral health, mental health, and substance abuse professionals and facilities (see S. 1517), S6597 [18SE] (see S. 1685), S7951 [12NO] (see H.R. 2957), H5343 [1AU]

——— incentivize the development of abuse-deterrent drugs (see H.R. 486), H342 [4FE]

——— promote development of meaningful treatments for patients (see H.R. 3091), H5546 [12SE] (see H.R. 3116), H5588 [17SE]

——— reduce prescription drug misuse and abuse (see S. 1657), S7876 [6NO]

——— reform medical liability system, improve access to health care for rural and indigent patients, and enhance access to affordable prescription drugs (see S. 1860), S9051 [19DE]

Holder, Attorney General: express no confidence and call for resignation due to lack of monitoring and actions relative to operations transferring firearms to drug cartels in Mexico (see H. Res. 35), H177 [18JA]

——— impeach (see H. Res. 411), H7110 [14NO]

Law enforcement: establish a border protection strategy for land borders of the U.S. and address the ecological and environmental impacts of border security infrastructure, measures, and activities (see H.R. 547), H411 [6FE]

——— establish a list of synthetic drugs known as analogues and prohibit most importation, amend sentencing for violations, and improve regulation relative to such analogues (see S. 1323), S5799 [18JY]

——— focus limited Federal resources on the most serious offenders by modifying sentencing guidelines for certain drug offenses (see S. 1410), S6126 [31JY] (see H.R. 3382), H6951 [30OC]

——— impose enhanced penalties for certain drug offense that take place on Federal property (see H.R. 2270), H3215 [5JN]

——— improve prosecution of the sale and distribution of synthetic drugs known as analogues (see S. 1322), S5799 [18JY]

——— increase evidentiary standard for drug convictions and require screening of law enforcement officers or others acting under color of law participating in drug task forces (see H.R. 88), H30 [3JA]

Marijuana: decriminalize marijuana at the Federal level and leave States the power to regulate marijuana similar to the power to regulate alcohol (see H.R. 499), H370 [5FE]

——— exempt real property from civil forfeiture due to medical-marijuana-related conduct authorized by State law (see H.R. 784), H595 [15FE]

——— prohibit Federal prosecution of residents who are acting in accordance with their State’s marijuana laws (see H.R. 1523), H1990 [12AP]

——— provide an affirmative defense for medical use in accordance with the laws of the States (see H.R. 710), H545 [14FE]

——— provide that Federal law shall not preempt State law (see H.R. 964), H981 [5MR]

——— reschedule under the Controlled Substances Act and allow for medicinal use in accordance with State laws (see H.R. 689), H545 [14FE]

Medicaid: remove exclusion from medical assistance of items and services for patients in mental institutions (see H.R. 2757), H4825 [19JY]

Medicare: adjust part B and D premiums for high-income beneficiaries (see S. 1198), S4792 [20JN]

——— apply exceptions process fairly for tiered formulary drugs in prescription drug plans (see S. 1365), S5968 [25JY] (see H.R. 2827), H5088 [25JY]

——— authorize the Dept. of HHS to negotiate lower covered part D prescription drug prices for beneficiaries (see S. 77), S213 (see S. 117), S214 [23JA]

——— count the negotiated price of drugs provided free or at nominal charge under compassionate treatment programs towards incurred out-of-pocket costs (see H.R. 1239), H1567 [18MR]

——— cover supplies associated with insulin injection, home needle removal, decontamination, and disposal devices, and disposal of needles and syringes through a sharps-by-mail or similar program (see S. 672), S2500 [9AP] (see H.R. 2977), H5344 [1AU]

——— deliver a meaningful drug benefit and lower prescription drug prices (see S. 408), S1011 [28FE] (see H.R. 928), H815 [28FE]

——— eliminate delay in including oral-only end-stage renal disease-related drugs in the prospective payment system (see H.R. 413), H281 [23JA]

——— encourage use of dispensing techniques that foster efficiency and reduce wasteful dispensing of outpatient prescription drugs in long-term care facilities (see S. 1493), S6327 [10SE]

——— exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals (see S. 806), S2960 [24AP] (see H.R. 800), H596 [15FE]

——— extended coverage of immunosuppressive drugs for kidney transplant patients and other renal dialysis provisions (see S. 323), S708 [13FE]

——— improve access to medication therapy management under part D (see S. 557), S1785 [13MR]

——— include information on the coverage of intensive behavioral therapy for obesity in the ‘‘Medicare and You Handbook’’ and coordinate programs to prevent and treat obesity (see S. 1184), S4673 [19JN] (see H.R. 2415), H3758 [18JN]

——— permit direct payment to pharmacies for certain compounded drugs for a specific beneficiary for use through an implanted infusion pump (see S. 914), S3326 [9MY] (see H.R. 232), H84 [14JA]

——— prevent budget sequestration from impacting payment for physician-administered drugs (see H.R. 1416), H1856 [9AP]

——— provide coverage options for beneficiaries under the original fee-for-service program through a Medicare Link program (see H.R. 3567), H7310 [20NO]

——— provide eligible individuals with single chronic diseases access to medication therapy management under the part D prescription drug program (see H.R. 1024), H1327 [7MR]

——— provide entitlement to immunosuppressive drugs for kidney transplant recipients (see H.R. 1325), H1821 [21MR] (see H.R. 1428), H1856 [9AP]

——— provide for a prescription drug plan safety program to prevent fraud and abuse in the dispensing of controlled substances (see H.R. 3392), H6951 [30OC]

——— provide for pharmacy benefits manager standards under the prescription drug program, establish basic audit standards and transparency of payment methodology of pharmacies, and provide recoupment returns (see S. 867), S3091 [6MY]

——— require drug manufacturers to provide rebates for drugs dispensed to low-income individuals under the prescription drug benefit program (see S. 740), S2684 [16AP] (see H.R. 1588), H2066 [16AP]

——— require sponsors of prescription drug plans to implement procedures to prevent fraud and abuse (see H.R. 2960), H5343 [1AU]

——— require the Dept. of HHS to negotiate lower covered part D prescription drug prices for beneficiaries (see H.R. 1102), H1357 [12MR]

Mental health: reauthorize and improve programs related to mental health and substance use disorders (see S. 689), S2501 [9AP]

National Commission on Federal Marijuana Policy: establish (see H.R. 1635), H2157 [18AP]

National Criminal Justice Commission: establish (see H.R. 446), H315 [1FE]

National security: improve border security (see H.R. 2872), H5259 [31JY]

Office of National Drug Control Policy: increase public awareness on dangers of synthetic drugs through national youth antidrug media campaign (see H.R. 2148), H2953 [23MY]

Patient Protection and Affordable Care Act: repeal amendments which disqualify expenses for over-the-counter drugs under health savings accounts and health flexible spending arrangements (see S. 1647), S7829 [5NO] (see H.R. 2835), H5088 [25JY]

Pharmaceuticals: allow personal importation and reimportation of prescription drugs (see H.R. 3715), H8107 [12DE]

——— clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers (see S. 1128), S4212 [11JN] (see H.R. 2315), H3287 [11JN]

——— preserve effectiveness of medically important antimicrobials used in treatment of human and animal diseases (see S. 1256), S5498 [27JN] (see H.R. 1150), H1425 [14MR]

——— prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market (see S. 214), S469 [4FE] (see H.R. 3709), H7687 [11DE]

——— provide incentives for investment in research and development for new medicines and enhance access to new medicines (see S. 627), S2026 [20MR]

Pharmacies: ensure and foster safety and quality of care and competitive marketplace by exempting independent pharmacies from antitrust laws in negotiations with health and health insurance providers (see H.R. 1188), H1426 [14MR]

Public welfare programs: require States to implement drug testing program for applicants and recipients of assistance under the Temporary Assistance for Needy Families Program (see S. 873), S3158 [7MY] (see H.R. 909), H815 [28FE] (see H.R. 1069), H1355 [12MR]

Red Ribbon Week: support goals and ideals (see S. Res. 279), S7728 [31OC] (see H. Res. 382), H6594 [14OC]

Sabin Vaccine Institute: anniversary (see H. Res. 114), H1396 [13MR]

Schools: prohibit Federal education funding for elementary or secondary schools that provide access to emergency postcoital contraception (see H.R. 2943), H5343 [1AU]

Social Security: prevent fraud and abuse in Medicare, Medicaid, and State Children’s Health Insurance Program and require National Provider Identifiers for reimbursement of prescriptions under Medicare part D (see H.R. 2828), H5088 [25JY]

——— reform (see H.R. 1374), H1824 [21MR]

Sports: improve integrity and safety of interstate horseracing (see S. 973), S3569 [16MY] (see H.R. 2012), H2716 [16MY]

Taxation: allow deductions and credits relative to expenditures in connection with marijuana sales conducted in compliance with State law (see H.R. 2240), H3094 [4JN]

——— deny any deduction for direct-to-consumer advertisements of prescription drugs (see H.R. 923), H815 [28FE]

——— include vaccines against seasonal influenza within the definition of taxable vaccines (see S. 391), S943 [27FE] (see H.R. 475), H341 [4FE]

——— provide for the taxation of marijuana (see H.R. 501), H370 [5FE]

U.S. Sentencing Commission: establish penalties for causing environmental damage while cultivating marijuana or other controlled substances on Federal lands or trespassing on private property (see S. 1889), S9105 [20DE] (see H.R. 2735), H4724 [18JY]

Unemployment: prevent the payment of unemployment compensation to individuals discharged for drug or alcohol use (see H.R. 1172), H1426 [14MR]

——— require drug testing as a condition for application and receipt of unemployment compensation (see H.R. 1277), H1717 [20MR]

——— require substance abuse risk assessment and targeted drug testing as a condition for receipt of unemployment compensation (see H.R. 3454), H6997 [12NO]

Veterinarians: allow transport and dispensing of controlled substances in the usual course of veterinary practice outside of the registered location (see S. 950), S3430 [14MY] (see S. 1171), S4521 [17JN] (see H.R. 1528), H1991 [12AP]

World Polio Day: support goals and ideals (see S. Res. 270), S7536 [16OC]

Cloture motions

FDA: strengthen regulation of human drug compounding and drug supply chain security (H.R. 3204), motion to proceed, S7923 [7NO], S7949 [12NO], S8027 [14NO]

Essays

State of the Union: Jonah Blatt, S703 [13FE]

Letters

FDA continuing appropriations: several organizations, H6330 [7OC]

Medicare and Medicaid budget cuts: Alliance for a Just Society, S1017 [28FE]

Medicare Prescription Drug Savings and Choice Act: Max Richtman, National Committee To Preserve Social Security & Medicare, S1018 [28FE]

Safeguarding America’s Pharmaceuticals Act: several organizations, H2982, H2983 [3JN]

——— Stanley C. Weisser, California State Board of Pharmacy, H2981 [3JN]

Lists

Expiring Dept. of Defense authorities, S8549 [9DE], S8959 [18DE]

Organizations supporting H.R. 3204, Drug Quality and Security Act, S8028 [14NO]

Staff and Senators who worked on H.R. 3204, Drug Quality and Security Act, S8025 [14NO]

Messages

National Drug Control Strategy: President Obama, S2958 [24AP], H2276 [24AP]

National Emergency Relative to Narcotics Traffickers in Colombia: President Obama, S7535 [16OC], H6615 [16OC]

Motions

FDA: making continuing appropriations (H.J. Res. 77), H6332, H6333 [7OC]

——— strengthen regulation of human drug compounding and drug supply chain security (H.R. 3204), S7841 [6NO], S7891 [7NO], S7937 [12NO], S7973 [13NO], S8026 [14NO]

Remarks in House

American Pharmacists Month: observance, E1718 [20NO]

ATF: blocking of publication of book relative to operations transferring firearms to drug cartels in Mexico, H6348 [8OC]

Bucks Promise for Youth and Communities (organization): Community Anti-Drug Coalitions of America and Consumer Healthcare Products Association Dose of Prevention Award recipient, H353 [5FE]

Committee on Oversight and Government Reform (House): hold bipartisan public hearings with testimony from persons having knowledge relative to operations transferring firearms to drug cartels, H3238 [6JN]

Contraceptives: establish certain duties for pharmacies to ensure provision of FDA-approved contraception (H.R. 728), E148 [14FE]

Crime: decriminalization of marijuana, H345 [5FE]

——— effect of immigration on domestic drug control, H5086 [25JY]

Dept. of Agriculture: allow States to implement drug testing program for Supplemental Nutrition Assistance Program applicants, H3885, H3886 [19JN], H6511 [11OC]

Dept. of HHS: award certain asthma-related grants to States that permit trained school personnel to administer epinephrine (H.R. 2094), H5145–H5147 [30JY]

——— conduct or support a comprehensive study comparing total health outcomes, including risk of autism, in vaccinated populations and unvaccinated populations (H.R. 1757), E576 [26AP]

Dept. of Homeland Security: develop a comprehensive strategy to gain and maintain operational control of the international borders of the U.S., H4133 [27JN]

——— develop a comprehensive strategy to gain and maintain operational control of the international borders of the U.S. (H.R. 1417), H3126 [5JN], H6468 [10OC], H7387 [2DE], H8102 [12DE]

Dept. of Veterans Affairs: prohibit funding to implement directive prohibiting access to clinical programs for veterans participating in State-approved marijuana programs, H3073 [4JN]

Diseases: require group and individual health insurance coverage and group health plans to cover oral cancer drugs on terms no less favorable than for cancer medications administered by a health care provider (H.R. 1801), H2256 [24AP], H7199 [19NO]

Dixon, Charley G., Jr.: Knox County, KY, Chamber of Commerce Man of the Year award recipient, E1589 [29OC]

Economy: national objectives priority assignments, H819 [4MR]

FDA: decision to allow over-the-counter access to emergency-contraceptive drug Plan B One Step without age restriction, H3639 [14JN]

——— encourage use of abuse-deterrent formulations of drugs (H. Res. 161), H2030 [16AP]

——— enhance reporting requirements pertaining to use of antimicrobial drugs in food animals (H.R. 820), H2991 [3JN]

——— making continuing appropriations (H.J. Res. 77), H6326–H6334 [7OC], E1467 [9OC]

——— making continuing appropriations (H.J. Res. 77), consideration (H. Res. 371), H6244–H6254 [4OC]

——— making continuing appropriations (H.J. Res. 77), motion to recommit, H6333 [7OC]

——— prohibit wholesalers from purchasing prescription drugs from pharmacies and enhance information and transparency of drug wholesalers engaged in interstate commerce, E784 [4JN]

——— reauthorize user fee programs relating to new animal drugs and generic new animal drugs (S. 622), H2984–H2993 [3JN], E829 [10JN]

——— strengthen and secure the pharmaceutical distribution supply chain to protect consumers from counterfeit pharmaceuticals, H5961, H5962, H5965 [28SE]

——— strengthen and secure the pharmaceutical distribution supply chain to protect consumers from counterfeit pharmaceuticals (H.R. 1919), H2968–H2984 [3JN], E784, E796 [4JN], E883 [17JN]

——— strengthen and secure the pharmaceutical distribution supply chain to protect consumers from counterfeit pharmaceuticals (S. 957), H2979 [3JN]

——— strengthen regulation of compounding drugs by pharmacies, H5961, H5962, H5965 [28SE]

——— strengthen regulation of compounding drugs by pharmacies (H.R. 3019), E1223 [2AU]

——— strengthen regulation of human drug compounding and drug supply chain security (H.R. 3204), H5946–H5965 [28SE]

Firearms: enhance criminal penalties for straw purchasers of firearms (H.R. 404), H1392 [13MR]

Fredericksburg, VA: tribute to Lance Corporal Caleb Power Young Marine Unit Red Ribbon Week observance, E1721 [20NO]

Health: address prescription drug abuse, H1873 [10AP]

——— continue efforts to prevent and eradicate polio, H2557 [9MY]

——— health care programs funding, H1670 [20MR]

Holder, Attorney General: call for resignation due to lack of monitoring and actions relative to operations transferring firearms to drug cartels in Mexico, H2943 [23MY], H3296 [12JN]

——— express no confidence and call for resignation due to lack of monitoring and actions relative to operations transferring firearms to drug cartels in Mexico, H2944 [23MY], H4504 [16JY], H4983 [24JY], H5054 [25JY], H5184 [31JY]

India: address actions that infringe upon U.S. intellectual property rights, H7170 [18NO]

King, Representative Steve: characterization of remarks on Hispanic community, H4991, H4992, H4993 [24JY]

Marijuana: reschedule under the Controlled Substances Act and allow for medicinal use in accordance with State laws (H.R. 689), E150 [14FE]

Medicare: prevent budget sequestration from impacting payment for physician-administered drugs (H.R. 1416), H1867 [10AP]

——— reform, H437 [12FE]

——— tribute to part D prescription drug benefit program, H3369 [13JN]

National security: improve border security, H4203 [8JY], H4518 [16JY], H6447 [9OC]

Oregon: tribute to Veterans Treatment Court volunteers, E1817 [9DE]

Orphan Drug Act: anniversary, E13 [4JA]

Pharmaceuticals: clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers (H.R. 2315), unanimous-consent agreement, H5055 [25JY]

——— preserve effectiveness of medically important antimicrobials used in treatment of human and animal diseases (H.R. 1150), H2991, H2992 [3JN], H6623 [16OC], E299 [14MR]

Pharmacies: ensure and foster safety and quality of care and competitive marketplace by exempting independent pharmacies from antitrust laws in negotiations with health and health insurance providers (H.R. 1188), H5040–H5044 [24JY]

Public welfare programs: require States to implement drug testing program for applicants and recipients of assistance under the Temporary Assistance for Needy Families Program (H.R. 909), E221 [28FE]

Rotary International: commend efforts to prevent and eradicate polio, E1548 [23OC]

Rush, Lee: Community Anti-Drug Coalitions of America Advocate of the Year award recipient, H399 [6FE]

Social Security: reform, H2715 [16MY]

Taxation: allow deductions and credits relative to expenditures in connection with marijuana sales conducted in compliance with State law (H.R. 2240), H3021 [4JN], E794 [4JN]

——— include vaccines against seasonal influenza within the definition of taxable vaccines (H.R. 475), H3704, H3705 [18JN]

——— provide for the taxation of marijuana (H.R. 501), E98 [5FE]

Terrorism: label drug cartels as foreign terrorist organizations, H1553 [18MR]

Unemployment: prevent the payment of unemployment compensation to individuals discharged for drug or alcohol use (H.R. 1172), E305 [14MR]

Whitehouse Station, NJ: anniversary of Anderson House women’s addiction center, E87 [4FE]

World Polio Day: observance, E1548 [23OC]

Remarks in Senate

ATF: dedication of Ariel Rios Reflecting Pool, S6324 [10SE]

Commission on Native Children: establish (S. 1622), S7678–S7680 [30OC]

Controlled Substances Act: exclude industrial hemp from the definition of marijuana (S. 359), S783 [14FE]

Crime: enhance penalties for marketing controlled substances to minors (S. 1686), S7961 [12NO]

Dept. of HHS: award certain asthma-related grants to States that permit trained school personnel to administer epinephrine (H.R. 2094), S7778 [31OC]

——— award certain asthma-related grants to States that permit trained school personnel to administer epinephrine (S. 1503), S6448 [12SE]

——— develop an antimicrobial resistance research strategic plan, S6866 [24SE]

——— provide States with incentives to require elementary and secondary schools to maintain, and permit school personnel to administer, epinephrine, S3525 [15MY]

Dept. of Homeland Security: develop a comprehensive strategy to gain and maintain operational control of the international borders of the U.S., S4037, S4041–S4043 [10JN], S4073, S4078 [11JN], S4365, S4383–S4388 [12JN], S4551, S4561–S4565 [18JN], S4626, S4641, S4651 [19JN], S4730–S4732, S4734–S4737, S4786 [20JN]

——— develop a comprehensive strategy to gain and maintain operational control of the international borders of the U.S. (H.R. 1417), S6101 [31JY]

——— develop a comprehensive strategy to gain and maintain operational control of the international borders of the U.S. (S. 683), S2482 [9AP]

——— reduce trafficking of drugs across the Southwest border, S4465 [13JN]

Dept. of Justice: establish the Alaska Safe Families and Villages Demonstration Project, S487 [7FE]

——— provide the Depts. of Defense and Veterans Affairs authority to establish a prescription drug take-back program for Armed Forces members and veterans, S8438 [21NO]

——— provide the Depts. of Defense and Veterans Affairs authority to establish a prescription drug take-back program for Armed Forces members and veterans (S. 1089), S3957 [4JN]

——— provide with additional tools to target extraterritorial drug trafficking activity (S. 706), S2591 [11AP]

Drug abuse: establish a commission to coordinate efforts to reduce prescription drug abuse (S. 1277), S5706 [16JY]

FDA: allow fast track approval of certain orphan drugs, S3002 [25AP]

——— clarify regulation of animal drug compounding, S8071, S8072 [18NO]

——— making continuing appropriations (H.J. Res. 77), S7200 [4OC], S7263 [7OC], S7309 [8OC], S7311 [9OC]

——— reauthorize user fee programs relating to new animal drugs and generic new animal drugs (S. 622), S3275 [8MY]

——— strengthen regulation of compounding drugs by pharmacies (H.R. 2186), S7967 [13NO]

——— strengthen regulation of human drug compounding and drug supply chain security (H.R. 3204), S7800 [4NO], S7802 [5NO], S7864 [6NO], S8026–S8030 [14NO], S8071–S8076, S8079, S8080 [18NO]

——— strengthen regulation of human drug compounding and drug supply chain security (H.R. 3204), motion to proceed, S7846 [6NO], S7938, S7940–S7944 [12NO], S7965, S7967–S7970, S7974, S7981, S7985 [13NO], S8013, S8024 [14NO]

——— strengthen regulation of human drug compounding and drug supply chain security (H.R. 3204), unanimous-consent agreement, S8071 [18NO]

——— strengthen regulation of human drug compounding and drug supply chain security (H.R. 3204), unanimous-consent request, S7984, S7985 [13NO], S8029, S8030 [14NO]

Firearms: enhance criminal penalties for straw purchasers of firearms, S2484 [9AP], S2538, S2551 [10AP], S2575, S2577 [11AP], S3503 [15MY]

GAO: report on duplication within the Federal Government relative to drug abuse prevention and treatment programs, S3012 [25AP]

Government regulations: increase Federal oversight of prescription opioid treatment and assistance to States in reducing opioid abuse, diversion, and deaths (S. 348), S779 [14FE]

Law enforcement: establish a list of synthetic drugs known as analogues and prohibit most importation, amend sentencing for violations, and improve regulation relative to such analogues (S. 1323), S5801 [18JY]

——— focus limited Federal resources on the most serious offenders by modifying sentencing guidelines for certain drug offenses (S. 1410), S6184 [1AU]

Lexington, KY: tribute to Chrysalis House, S2141 [21MR]

Medicare: deliver a meaningful drug benefit and lower prescription drug prices (S. 408), S1015 [28FE]

——— expansion of Part D, S6875, S6876 [24SE]

——— extended coverage of immunosuppressive drugs for kidney transplant patients and other renal dialysis provisions (S. 323), S714 [13FE]

——— permit direct payment to pharmacies for certain compounded drugs for a specific beneficiary for use through an implanted infusion pump (S. 914), S3330 [9MY]

——— require drug manufacturers to provide rebates for drugs dispensed to low-income individuals under the prescription drug benefit program (S. 740), S2687 [16AP]

Mental health: reauthorize and improve programs related to mental health and substance use disorders, S2730 [17AP], S2781 [18AP]

National Association of Chain Drug Stores: observance of RxIMPACT Day, S1707 [12MR]

National Medicine Abuse Awareness Month: observance, S7611 [29OC], S7668 [30OC]

National security: improve border security, S4030 [10JN], S4366–S4368, S4396–S4400 [12JN]

Patient Protection and Affordable Care Act: eliminate cap on flexible spending account contributions and requirement for prescriptions for over-the-counter drugs under health savings accounts and flexible spending accounts, S2302 [22MR]

Pharmaceuticals: preserve effectiveness of medically important antimicrobials used in treatment of human and animal diseases (S. 1256), S5503 [27JN]

Senate: legislative priorities, S7563–S7565 [28OC]

Social Security: historical context of Republican Congressional opposition to instituting Social Security and Medicare relative to Patient Protection and Affordable Care Act implementation, S6875 [24SE]

Taxation: include vaccines against seasonal influenza within the definition of taxable vaccines (H.R. 475), S4725 [19JN]

——— include vaccines against seasonal influenza within the definition of taxable vaccines (H.R. 475), unanimous-consent agreement, S2904 [23AP]

U.S. Sentencing Commission: establish penalties for causing environmental damage while cultivating marijuana or other controlled substances on Federal lands or trespassing on private property (S. 1889), S9107 [20DE]

Veterinarians: allow transport and dispensing of controlled substances in the usual course of veterinary practice outside of the registered location (S. 1171), S4523 [17JN]

——— allow transport and dispensing of controlled substances in the usual course of veterinary practice outside of the registered location (S. 950), S9043 [19DE]

Willisburg, KY: tribute to Isaiah House, S2141 [21MR]

Reports

Benefits of the Health Care Reform Law in Arkansas’ 2d Congressional District: Committees on Energy and Commerce, Ways and Means, and Education and the Workforce (House) Democratic Staff, H4551 [17JY]

Benefits of the Health Care Reform Law in Florida’s 12th Congressional District: Committees on Energy and Commerce, Ways and Means, and Education and the Workforce (House) Democratic Staff, H4553 [17JY]

Benefits of the Health Care Reform Law in Georgia’s 11th Congressional District: Committees on Energy and Commerce, Ways and Means, and Education and the Workforce (House) Democratic Staff, H4569 [17JY]

Benefits of the Health Care Reform Law in Indiana’s 9th Congressional District: Committees on Energy and Commerce, Ways and Means, and Education and the Workforce (House) Democratic Staff, H4559 [17JY]

Benefits of the Health Care Reform Law in Michigan’s 10th Congressional District: Committees on Energy and Commerce, Ways and Means, and Education and the Workforce (House) Democratic Staff, H4567 [17JY]

Benefits of the Health Care Reform Law in Minnesota’s 3d Congressional District: Committees on Energy and Commerce, Ways and Means, and Education and the Workforce (House) Democratic Staff, H4559 [17JY]

Benefits of the Health Care Reform Law in Ohio’s 16th Congressional District: Committees on Energy and Commerce, Ways and Means, and Education and the Workforce (House) Democratic Staff, H4554 [17JY]

Benefits of the Health Care Reform Law in Pennsylvania’s 18th Congressional District: Committees on Energy and Commerce, Ways and Means, and Education and the Workforce•20(House) Democratic Staff, H4552 [17JY]

Benefits of the Health Care Reform Law in Tennessee’s 1st Congressional District: Committees on Energy and Commerce, Ways and Means, and Education and the Workforce (House) Democratic Staff, H4560 [17JY]

Benefits of the Health Care Reform Law in Tennessee’s 6th Congressional District: Committees on Energy and Commerce, Ways and Means, and Education and the Workforce (House) Democratic Staff, H4570 [17JY]

Benefits of the Health Care Reform Law in Tennessee’s 7th Congressional District: Committees on Energy and Commerce, Ways and Means, and Education and the Workforce (House) Democratic Staff, H4556 [17JY]

Benefits of the Health Care Reform Law in Texas’ 8th Congressional District: Committees on Energy and Commerce, Ways and Means, and Education and the Workforce (House) Democratic Staff, H4548 [17JY]

Benefits of the Health Care Reform Law in Texas’ 26th Congressional District: Committees on Energy and Commerce, Ways and Means, and Education and the Workforce (House) Democratic Staff, H4542 [17JY]

Benefits of the Health Care Reform Law in Virginia’s 5th Congressional District: Committees on Energy and Commerce, Ways and Means, and Education and the Workforce (House) Democratic Staff, H4562 [17JY]

Benefits of the Health Care Reform Law in Virginia’s 7th Congressional District: Committees on Energy and Commerce, Ways and Means, and Education and the Workforce (House) Democratic Staff, H4565 [17JY]

Benefits of the Health Care Reform Law in Washington’s 5th Congressional District: Committees on Energy and Commerce, Ways and Means, and Education and the Workforce (House) Democratic Staff, H4566 [17JY]

Benefits of the Health Care Reform Law in Wisconsin’s 1st Congressional District: Committees on Energy and Commerce, Ways and Means, and Education and the Workforce (House) Democratic Staff, H4548 [17JY]

Reports filed

Border Security Results Act: Committee on Homeland Security (House) (H.R. 1417) (H. Rept. 113–87), H2802 [20MY]

Consideration of H.J. Res. 75–80 and 82–85, Various Federal Agencies and Programs Continuing Appropriations and H.R. 3223, Federal Employee Retroactive Pay Fairness Act: Committee on Rules (House) (H. Res. 371) (H. Rept. 113–242), H6223 [3OC]

FDA User Fee Programs Relating to New Animal Drugs and Generic New Animal Drugs Reauthorization: Committee on Health, Education, Labor, and Pensions (Senate) (S. 622), S2025 [20MR]

FDA User Fee Programs Relating to New Animal Drugs Reauthorization: Committee on Energy and Commerce (House) (H.R. 1407) (H. Rept. 113–188), H5395 [2AU]

Medical Preparedness Allowable Use Act: Committee on Homeland Security (House) (H.R. 1791) (H. Rept. 113–273), H7352 [21NO]

Mental Health Awareness and Improvement Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 689), S2589 [11AP]

Pharmaceutical Compounding Quality and Accountability Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 959), S4673 [19JN]

Safeguarding America’s Pharmaceuticals Act: Committee on Energy and Commerce (House) (H.R. 1919) (H. Rept. 113–93), H3014 [3JN]

School Access to Emergency Epinephrine Act: Committee on Energy and Commerce (House) (H.R. 2094) (H. Rept. 113–182), H5172 [30JY]

——— Committee on Health, Education, Labor, and Pensions (Senate) (H.R. 2094), S7673 [30OC]

Rulings of the Chair

FDA: making continuing appropriations (H.J. Res. 77), H6333 [7OC]

Statements

Safeguarding America’s Pharmaceuticals Act: Pew Charitable Trust, H2981 [3JN]

What They Are Saying About Border Security Metrics: several border security experts, S4735 [20JN]

Texts of

H. Res. 371, consideration of H.J. Res. 75–80 and 82–85, various Federal agencies and programs continuing appropriations and H.R. 3223, Federal Employee Retroactive Pay Fairness Act, H6244 [4OC]

H.J. Res. 77, FDA continuing appropriations, H6326 [7OC]

H.R. 475, include vaccines against seasonal influenza within the definition of taxable vaccines, H3704 [18JN]

H.R. 1911, Safeguarding America’s Pharmaceuticals Act, H2969–H2978 [3JN]

H.R. 2094, School Access to Emergency Epinephrine Act, H5145 [30JY]

H.R. 3204, Drug Quality and Security Act, H5946–H5960 [28SE]

S. 323, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act, S715 [13FE]

S. 359, Industrial Hemp Farming Act, S784 [14FE]

S. 408, Medicare Prescription Drug Savings and Choice Act, S1016 [28FE]

S. 622, FDA reauthorization of user fee programs relating to new animal drugs and generic new animal drugs, S3275–S3282 [8MY]

S. 622, FDA user fee programs relating to new animal drugs and generic new animal drugs reauthorization, H2984–H2991 [3JN]

S. 706, Transnational Drug Trafficking Act, S2591 [11AP]

S. 1323, Protecting Our Youth From Dangerous Synthetic Drugs Act, S5802 [18JY]

S. 1410, Smarter Sentencing Act, S6129 [31JY]

S. 1503, School Access to Emergency Epinephrine Act, S6449 [12SE]

S. 1686, Saving Kids From Dangerous Drugs Act, S7962 [12NO]

S. 1889, Protecting Lands Against Narcotics Trafficking (PLANT) Act, S9107 [20DE]

S. Res. 97, FDA encouragement of use of abuse-deterrent formulations of drugs, S2654 [15AP]

S. Res. 178, DEA anniversary, S4796 [20JN]

S. Res. 270, support goals and ideals of World Polio Day, S7537 [16OC]

S. Res. 279, support goals and ideals of Red Ribbon Week, S7732 [31OC]